Pemphigus—The Crux of Clinics, Research, and Treatment during the COVID-19 Pandemic
Pemphigus is a rare autoimmune disease characterised by the production of pathogenic autoantibodies in response to different desmosome proteins. The pathophysiological process leads to the development of blisters and erosions on mucosal and/or skin surfaces. The classical clinical variants of pemphi...
Guardado en:
Autores principales: | Branka Marinović, Joško Miše, Ines Lakoš Jukić, Zrinka Bukvić Mokos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/405b8992aae6401696d41ee5350fae14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Giulio Fortuna, et al.
Publicado: (2021) -
IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Salama Hegazy, et al.
Publicado: (2016) -
Pénfigo vulgar tipo cutáneo: Caso clínico
por: Bello,Cristina, et al.
Publicado: (2013) -
Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity
por: Soheil Tavakolpour, et al.
Publicado: (2019) -
Efficacy of combination therapy of steroid and methotrexate for refractory pemphigus
por: Miwa Kanaoka, et al.
Publicado: (2021)